GlobalData

Vaccination for pneumococcal disease was only introduced in children in late 2017 across three Indian states, and vaccination in…

The healthcare industry reported 62 VC deals worth US$0.9-bn in February 2020, compared to the last 12-month average (February…

Amgen and Allergan’s biosimilar candidate to Roche’s Rituxan (rituximab) shows the greatest potential of these drugs Out of all…

ODDs have been a focus of interest from the pharma industry for many years, with many companies enticed by the benefits of the…

CMS will be responsible for the development, registration and commercialisation of desidustat in China, while Zydus will receive…

There are 87 first-in-class products that act on a range of 50 molecular targets, which can broadly be classified as host or viral…

According to GlobalData, three big ticket deals together contributed 63 per cent to the total deal value in the month

The company’s latest report, ‘Pneumococcal Vaccines: Epidemiology Forecast to 2028’, reveals that the average pediatric…

The company’s latest report, ‘Pneumococcal Vaccines: Epidemiology Forecast to 2028’, reveals that the average pediatric…

The industry also reported 85 venture capital (VC) deals worth US$1.7 billion in October 2019, compared to the last 12-month…